An Evidence-Based medicine approach to Beta-blocker therapy in patients with cirrhosis
- 1 June 2004
- journal article
- case report
- Published by Elsevier in The American Journal of Medicine
- Vol. 116 (11) , 759-766
- https://doi.org/10.1016/j.amjmed.2004.03.006
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Complications of cirrhosis. I. Portal hypertensionJournal of Hepatology, 2000
- Pharmacological Treatment of Portal Hypertension: An Evidence-Based ApproachSeminars in Liver Disease, 1999
- Portal hypertension and variceal bleeding: An AASLD single topic symposium†Hepatology, 1998
- The treatment of portal hypertension: A meta-analytic reviewHepatology, 1995
- β-blockade prevents recurrent gastrointestinal bleeding in well-compensated patients with alcoholic cirrhosis: A multicenter randomized controlled trialHepatology, 1989
- Randomized controlled study of propranolol for prevention of recurrent esophageal varices bleeding in patients with cirrhosisLiver International, 1989
- Nadolol for Prevention of Variceal Rebleeding in Cirrhosis: A Controlled Clinical TrialDigestion, 1987
- Propranolol for the prevention of recurrent variceal hemorrhage: A controlled trialHepatology, 1986
- A Randomized Controlled Study of Propranolol for Prevention of Recurrent Gastrointestinal Bleeding in Patients with Cirrhosis: A Final ReportHepatology, 1984
- Controlled Trial of Propranolol for the Prevention of Recurrent Variceal Hemorrhage in Patients with CirrhosisNew England Journal of Medicine, 1983